Sleep Extension and Blood Pressure



Status:Recruiting
Healthy:No
Age Range:18 - 65
Updated:2/13/2019
Start Date:October 2016
End Date:December 2020
Contact:Carrie Witter
Email:CPLSLEEPEXT@mayo.edu
Phone:(507) 255-0492

Use our guide to learn which trials are right for you!

Trial Summary
Trial Overview
Inclusion Criteria

Lowering Blood Pressure by Sleep Extension: a Randomized, Controlled Trial

Emerging evidence suggests that approximately 30% of the US adult population sleeps less than
7 hours per night, and those who do exhibit 20-52% enhanced risk to develop cardiovascular
diseases and particularly hypertension. Since sleep curtailment is largely voluntary, sleep
deficiency can be corrected and its detrimental health consequences potentially reversed. The
purpose of the present proposal is to investigate the cardiovascular and metabolic effects of
sleep extension in prehypertensive and stage 1 hypertensive subjects who report habitual
short sleep.


- Age: 18 to 65 (inclusive)

- Gender: both males and females

- Body mass index (BMI): 18.5-34.9 kg/m2

- Habitual sleep duration: <7 hours

- Presence of either:

- Prehypertension: office systolic BP (SBP) 120-139 mmHg and/or diastolic BP (DBP)
80- 89 mmHg;

- Stage 1 hypertension: office SBP 140-159 mmHg and/or DBP 90-99 mmHg

- Either on no prescription medications (other than oral contraceptive pills, or
intrauterine devices) or on stable medical regimen for at least 1 month, if taking
prescription medications for chronic conditions

- Not pregnant or breast feeding and not intending to become pregnant or breast feed

- Not a current smoker or tobacco user

- Ability to provide written informed consent
We found this trial at
1
site
Mayo Clinic Rochester
200 First Street SW
Rochester, Minnesota 55905
507-284-2511
Mayo Clinic Rochester Mayo Clinic is a nonprofit worldwide leader in medical care, research and...
?
mi
from
Rochester, MN
Click here to add this to my saved trials